Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 9
2004 10
2005 13
2006 6
2007 10
2008 20
2009 18
2010 18
2011 12
2012 10
2013 15
2014 13
2015 10
2016 14
2017 18
2018 6
2019 9
2020 11
2021 7
2022 6
2023 10
2024 12
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV).
Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, Strnad P, Sterneck M, Settmacher U, Seehofer D, Schott E, Schnitzbauer AA, Schmidt HH, Schlitt HJ, Pratschke J, Pascher A, Neumann U, Manekeller S, Lammert F, Klein I, Kirchner G, Guba M, Glanemann M, Engelmann C, Canbay AE, Braun F, Berg CP, Bechstein WO, Becker T, Trautwein C; Collaborators:. Berg T, et al. Z Gastroenterol. 2024 Sep;62(9):1397-1573. doi: 10.1055/a-2255-7246. Epub 2024 Sep 9. Z Gastroenterol. 2024. PMID: 39250961 Free article. German. No abstract available.
Amendment „Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung)“ zur S2k-Leitlinie „Nicht-alkoholische Fettlebererkrankung“ (v.2.0/April 2022) der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, Denzer UW, Geier A, Hofmann WP, Hudert C, Karlas T, Krawczyk M, Longerich T, Lüdde T, Roden M, Schattenberg JM, Sterneck M, Tannapfel A, Lorenz P, Tacke F; Collaborators. Roeb E, et al. Z Gastroenterol. 2024 Jul;62(7):1077-1087. doi: 10.1055/a-2309-6052. Epub 2024 Jul 8. Z Gastroenterol. 2024. PMID: 38976985 German. No abstract available.
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence.
Keyl J, Keyl P, Montavon G, Hosch R, Brehmer A, Mochmann L, Jurmeister P, Dernbach G, Kim M, Koitka S, Bauer S, Bechrakis N, Forsting M, Führer-Sakel D, Glas M, Grünwald V, Hadaschik B, Haubold J, Herrmann K, Kasper S, Kimmig R, Lang S, Rassaf T, Roesch A, Schadendorf D, Siveke JT, Stuschke M, Sure U, Totzeck M, Welt A, Wiesweg M, Baba HA, Nensa F, Egger J, Müller KR, Schuler M, Klauschen F, Kleesiek J. Keyl J, et al. Among authors: baba ha. Nat Cancer. 2025 Feb;6(2):307-322. doi: 10.1038/s43018-024-00891-1. Epub 2025 Jan 30. Nat Cancer. 2025. PMID: 39885364 Free PMC article.
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.
Reimann P, Mavroeidi IA, Burghofer J, Taghizadeh H, Webersinke G, Kasper S, Schreil G, Morariu D, Reichinger A, Baba HA, Kirchweger P, Schuler M, Djanani A, Prager GW, Rumpold H, Benda M, Schneider EM, Mink S, Winder T, Doleschal B. Reimann P, et al. Cancer Immunol Immunother. 2024 Oct 3;73(12):251. doi: 10.1007/s00262-024-03842-y. Cancer Immunol Immunother. 2024. PMID: 39358611 Free PMC article.
[Liver biopsy diagnostics-times are changing].
Longerich T, Baba HA. Longerich T, et al. Among authors: baba ha. Pathologe. 2020 Sep;41(5):432-433. doi: 10.1007/s00292-020-00804-w. Pathologe. 2020. PMID: 32822014 German. No abstract available.
Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients.
Heij L, Hayat S, Reichel K, Maryam S, O'Rourke CJ, Tan X, van den Braber M, Verhoeff J, Halder M, Peisker F, Wiltberger G, Bednarsch J, Heise D, Deierl JC, Lang SA, Ulmer F, Luedde T, Dahl E, Jonigk D, Nolting J, Sivakumar S, Siveke J, Vondran F, Rocha FG, Baba HA, Hartmann S, Andersen JB, Hobloss Z, Ghallab A, Hengstler JG, Vallejo JJG, Kramann R, Neumann U. Heij L, et al. Among authors: baba ha. NPJ Precis Oncol. 2026 Jan 28;10(1):105. doi: 10.1038/s41698-026-01292-6. NPJ Precis Oncol. 2026. PMID: 41593214 Free PMC article.
235 results